Detecting and Localizing Recurrent Prostate Cancer with Axumin® (fluciclovine F 18) injection
Learn more about the challenges and imaging dilemmas associated with recurrent prostate cancer, and review Axumin’s clinical efficacy and safety data, along with guideline recommendations for Axumin use.
Company: Blue Earth Diagnostics Inc.
Contact: Maura Harrigan
The asset you are trying to access is locked. Please enter your access key to unlock.